Deep Learning Identifies PPMS Patients Who May Respond to Treatment
Deep learning identified subgroups of patients with primary progressive multiple sclerosis (PPMS) who may respond to disease-modifying therapy, researchers said. A trained model separated responders and non-responders across a range of predicted effect sizes,
Deep learning identified subgroups of patients with primary progressive multiple sclerosis (PPMS) who may respond to disease-modifying therapy, researchers said. A trained model separated responders and non-responders across a range of predicted effect sizes,
primary progressive multiple sclerosis, deep learning, disease-modifying therapy, effect sizes, subgroups, patients, PPMS, Researchers, model, responders, range
